Compare Edwards Lifesciences Corporation Common Stock (EW) vs MPLX LP (MPLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs MPLX LP — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while MPLX LP trades at $57.42 (market cap $57.84B). The key difference: MPLX LP is the larger of the two by market cap, and MPLX LP pays a 7.55% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | MPLX | |
|---|---|---|
Market Cap | $49.44B | $57.84B |
Volume | 3,508,027 | 1,104,749 |
Sector | Health | Energy |
52-Week High | $95.18 | $60.51 |
52-Week Low | $72.65 | $47.80 |
Enterprise Value | $45.90B | $82.94B |
Dividend Yield | — | 7.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MPLX trades at $57.05, down 1.25% with a bearish technical signal. The company maintains strong profitability with 40.45% net income margin and 33.95% ROE, though recent earnings missed expectations in two consecutive quarters. Analyst consensus remains strongly bullish with a $63.80 price target, representing 12% upside potential. Recent news highlights MPLX's resilience in volatile energy markets through fee-based revenue models and strong distribution coverage.
The outlook remains positive given strong cash flow generation and dividend sustainability, though risks include energy market volatility and recent earnings misses. With 68% analyst buy ratings and solid fundamentals, MPLX presents a compelling income opportunity despite near-term technical weakness and sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →
